Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099748 · ClinicalTrials.gov registry record · Phase 1
Estimate The Effect Of Lersivirine On The Pharmacokinetics Of S- And R-Methadone
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT01099748 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 13 participants.
The verdict
NCT01099748, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The objective of this study is to estimate the effect of lersivirine on the pharmacokinetics of R-methadone and S-methadone and to investigate the safety and tolerability of lersivirine when co-administered with methadone. Symptoms of methadone withdrawal will also be assessed.
Interventions
- DRUG Methadone
- DRUG Lersivirine + Methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01099748
The ClinicalTrials.gov registry entry for NCT01099748 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methadone is the first listed.
NCT01099748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01099748 about?
NCT01099748 is a clinical study titled "Estimate The Effect Of Lersivirine On The Pharmacokinetics Of S- And R-Methadone". The objective of this study is to estimate the effect of lersivirine on the pharmacokinetics of R-methadone and S-methadone and to investigate the safety and tolerability of lersivirine when co-administered with methadone. Symptoms of methadone withdrawal will also be assessed.
What is the current status of trial NCT01099748?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2010-05. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01099748?
The interventions under investigation include: Methadone (DRUG), Lersivirine + Methadone (DRUG).
Who is sponsoring clinical trial NCT01099748?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.